There are 3162 resources available
What are the types of progression?
Presenter: Stephane Champiat
Session: Which patients should we treat beyond progression and when should we stop?
Resources:
Slides
Webcast
1541MO - Leadership roles in oncology: Gender is still a barrier. Results from the new ESMO Women for Oncology Committee authorship and monitoring studies
Presenter: Helena Linardou
Session: Mini oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
1207MO - Neoadjuvant nivolumab monotherapy for high-risk clinical stage I non-small cell lung cancer: A phase II POTENTIAL study
Presenter: Yasuhiro Tsutani
Session: Mini oral session 2: Non-metastatic NSCLC
Resources:
Abstract
Slides
Webcast
Challenges of HLA, neoantigen, and immune biomarker testing for early phase immunomodulatory therapy trials
Presenter: Michal Bassani-Sternberg
Session: The evolving diagnostic landscape of early phase trials
Resources:
Webcast
The role of immunotherapy plus concurrent chemoradiation
Presenter: Dina Najjari Jamal
Session: How can we best manage locally-advanced and persistent cervical cancers?
Resources:
Slides
Webcast
CNS disease
Presenter: Nancy Lin
Session: Management of oligoprogressive disease
Resources:
Slides
Webcast
Mantle cell lymphoma
Presenter: Georg Hess
Session: Treatment of difficult lymphomas
Resources:
Webcast
Cardiovascular toxicities: Focus on myocarditis
Presenter: Evandro de Azambuja
Session: Improving the management of toxicities from immunotherapy
Resources:
Slides
Webcast
How to overcome biases to build Real World Evidence
Presenter: Antonis Valachis
Session: How Real World Data (RWD) are transforming oncology
Resources:
Slides
Webcast
Sex and gender: First steps towards tailored treatment
Presenter: Kathrin Heinrich
Session: New technology, new ideas: What is on the horizon for colorectal cancer?
Resources:
Slides
Webcast